Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Est contraindicada en pacientes con historia personal o familiar de carcinoma medular de tiroides o sndrome MEN 2
The other just delivered 28.7% body weight reduction in Phase 3 trials, numbers that rewrote what researchers thought was possible
Tirzepatide is administered once weekly via subcutaneous injection, with doses starting at 2.5 mg for a 4-week initiation period, then titrating every 4 weeks up to a maximum of 15 mg
Using a mix of 10mg and 20mg vials: One 10mg vial for weeks 1-4 (uses 8mg)
doi: 10.1186/s40659-021-00328-4
US$ 22.19
US$ 27.33
US$ 27.88
